Biochemical control and tolerance of HDR brachytherapy and 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer

被引：0
|
作者：
Bhatia, SK [1 ]
Yamada, J [1 ]
Cohen, GN [1 ]
Zaider, M [1 ]
Zelefsky, MJ [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
272
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] Tolerance of Source Position Accuracy in HDR Brachytherapy in the Era of 3-Dimensional Treatment Planning
    Gao, M.
    Roeske, J.
    Albuquerque, K.
    MEDICAL PHYSICS, 2010, 37 (06)
  • [22] FREQUENCY OF RESIDUAL NEOPLASM IN THE PROSTATE FOLLOWING 3-DIMENSIONAL CONFORMAL RADIOTHERAPY
    FORMAN, JD
    OPPENHEIM, T
    LIU, H
    MONTIE, J
    MCLAUGHLIN, PW
    PORTER, AT
    PROSTATE, 1993, 23 (03): : 235 - 243
  • [23] Evaluation of transabdominal ultrasonography prostate localization for 3-dimensional conformal radiotherapy
    Cattani, F.
    Jereczek-Fossa, BA.
    Garibaldi, C.
    Cambria, R.
    Zerini, D.
    Vavassori, A.
    Valenti, M.
    Serafini, F.
    TrovA, M.
    Orecchia, R.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S218 - S219
  • [24] Correlation of long-term biochemical outcome with post-treatment biopsy results for patients treated with 3-dimensional conformal radiotherapy for prostate cancer
    Zelefsky, MJ
    Chan, HM
    Fuks, Z
    Reuter, V
    Leibel, SA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S170 - S170
  • [25] Multiparametric imaging guided HDR interventional radiotherapy (brachytherapy) boost in localized prostate cancer: a multidisciplinary experience
    Tagliaferri, L.
    Alemanno, G.
    Fionda, B.
    Alitto, A. R.
    Frascino, V.
    Cellini, F.
    Lancellotta, V.
    Placidi, E.
    Morganti, A. G.
    Kovacs, G.
    Giordano, A.
    Manfredi, R.
    Valentini, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (09) : 4175 - 4184
  • [26] Intensity Modulated Radiation Therapy Replaces 3-Dimensional Conformal Radiotherapy as Prostate Cancer Treatment
    Elliott, Sean P.
    Adejoro, Oluwakayode O.
    Konety, Badrinath R.
    Jarosek, Stephanie L.
    Dusenbery, Kathryn E.
    Virnig, Beth A.
    JOURNAL OF UROLOGY, 2012, 187 (04): : 1253 - 1258
  • [27] Patient-Reported Outcomes After 3-Dimensional Conformal, Intensity-Modulated, or Proton Beam Radiotherapy for Localized Prostate Cancer
    Gray, Phillip J.
    Paly, Jonathan J.
    Yeap, Beow Y.
    Sanda, Martin G.
    Sandler, Howard. M.
    Michalski, Jeff M.
    Talcott, James A.
    Coen, John J.
    Hamstra, Daniel A.
    Shipley, William U.
    Hahn, Stephen M.
    Zietman, Anthony L.
    Bekelman, Justin E.
    Efstathiou, Jason A.
    CANCER, 2013, 119 (09) : 1729 - 1735
  • [28] HDR BRACHYTHERAPY BOOST FOR LOCALIZED PROSTATE CANCER: BIOCHEMICAL:PATHOLOGY DISEASE FREE SURVIVAL AND TOXICITY REPORT
    Martin, A. G.
    Vigneault, E.
    Bachand, F.
    Harel, F.
    Beaulieu, L.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S19 - +
  • [29] MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life
    Maenhout, Metha
    Peters, Max
    Moerland, Marinus A.
    Meijer, Richard P.
    van den Bosch, Maurice A. A. J.
    Frank, Steven J.
    Nguyen, Paul L.
    van Vulpen, Marco
    van Zyp, Jochem R. N. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (03) : 554 - 560
  • [30] Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
    Milosevic, Michael
    Warde, Padraig
    Menard, Cynthia
    Chung, Peter
    Toi, Ants
    Ishkanian, Adrian
    McLean, Michael
    Pintilie, Melania
    Sykes, Jenna
    Gospodarowicz, Mary
    Catton, Charles
    Hill, Richard P.
    Bristow, Robert
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 2108 - 2114
12345